Dr. Grania Brigden, the advisor on tuberculosis with MSF’s Access Campaign, describes how children with TB that could be treated often go without care because of a lack of effective diagnostic tools and approaches.
As the 18th International AIDS Conference (IAC) winds down here in Vienna, the word in the hallways is that the science is in: earlier initiation of treatment and improved antiretroviral (ARV) drug regimens are better for individual patients and communities, and may even ultimately reduce transmission of HIV.
The increase in availability of antiretroviral drugs (ARVs) used to treat HIV in recent years, backed by solid funding commitments, has given millions of people in poor countries a new lease on life. This is the case for tens of thousands of people living with HIV/AIDS in Malawi’s southern Thyolo district. Here, Olesi Ellemani Pasulani, clinical officer for Doctors Without Borders/Médecins Sans Frontières (MSF) at the Thyolo District Hospital, shares his perspective on how improved access to care has changed the lives of people living with HIV/AIDS and the healthcare workers who treat them.
Carol Calero is a field physician for Doctors Without Borders/Médecins Sans Frontières (MSF). Currently she is working in the nutritional emergency in southwestern Central African Republic (CAR). In this interview, she talks about being in the heart of a health emergency and of the positive cases that keeps her spirits up.